5-HT1A receptor responsivity in unipolar depression Evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and controls

[1]  K. Lesch,et al.  Zur Serotonin-Hypothese der Depression , 1990 .

[2]  K. Lesch,et al.  Corticotropin and cortisol secretion after central 5-hydroxytryptamine-1A (5-HT1A) receptor activation: effects of 5-HT receptor and beta-adrenoceptor antagonists. , 1990, The Journal of clinical endocrinology and metabolism.

[3]  D. Murphy,et al.  Long-term cortisol treatment impairs behavioral and neuroendocrine responses to 5-HT1 agonists in the rat. , 1989, Neuroendocrinology.

[4]  K. Lesch,et al.  Endocrine responses to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humans , 1989, Biological Psychiatry.

[5]  G. Kennett,et al.  8-OH-DPAT increases corticosterone but not other 5-HT1A receptor-dependent responses more in females. , 1989, European journal of pharmacology.

[6]  E. Nestler,et al.  Corticosterone differentially regulates the expression of Gs alpha and Gi alpha messenger RNA and protein in rat cerebral cortex. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Peroutka.  5-Hydroxytryptamine receptor subtypes: molecular, biochemical and physiological characterization , 1988, Trends in Neurosciences.

[8]  F. Holsboer.  Implications of altered limbic‐hypothalamicpituitary‐adrenocortical (LHPA)‐function for neurobiology of depression , 1988, Acta psychiatrica Scandinavica. Supplementum.

[9]  L. Silverton.  Crime and the schizophrenia spectrum: a diathesis‐stress model , 1988, Acta psychiatrica Scandinavica.

[10]  H. Meltzer,et al.  Stimulation of serum cortisol and prolactin secretion in humans by MK-212, a centrally active serotonin agonist , 1988, Biological Psychiatry.

[11]  K. Lesch,et al.  Corticotropin and Cortisol Response to Human CRH as a probe for HPA system integrity in major depressive disorder , 1988, Psychiatry Research.

[12]  H. Meltzer,et al.  5-hydroxytryptamine1A receptor-mediated effects of buspirone, gepirone and ipsapirone , 1988, Pharmacology Biochemistry and Behavior.

[13]  S. Stahl,et al.  Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration. , 1988, European journal of pharmacology.

[14]  J. Traber,et al.  5-HT1A receptor-related anxiolytics , 1987 .

[15]  H. Meltzer,et al.  Stimulation of corticosterone and beta-endorphin secretion in the rat by selective 5-HT receptor subtype activation. , 1987, European journal of pharmacology.

[16]  K. Fuxe,et al.  Biochemistry, molecular biology, and physiology of the glucocorticoid receptor. , 1987, Endocrine reviews.

[17]  L. D. van de Kar,et al.  Differential effects of serotonin (5-HT1A and 5-HT2) agonists and antagonists on renin and corticosterone secretion. , 1987, Neuroendocrinology.

[18]  P. Cowen.  Psychotropic drugs and human 5-HT neuroendocrinology , 1987 .

[19]  E. Melamed,et al.  Paraventricular nucleus serotonin mediates neurally stimulated adrenocortical secretion , 1987, Brain Research Bulletin.

[20]  E. Souza.  Serotonin and Dopamine Receptors in the Rat Pituitary Gland: Autoradiographic Identification, Characterization, and Localization* , 1986 .

[21]  D. Murphy,et al.  Use of serotonergic agents in the clinical assessment of central serotonin function. , 1986, The Journal of clinical psychiatry.

[22]  J. Tuomisto,et al.  Neurotransmitter regulation of anterior pituitary hormones. , 1985, Pharmacological reviews.

[23]  F. Holsboer,et al.  Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. , 1984, The New England journal of medicine.

[24]  G. Chrousos,et al.  The corticotropin-releasing hormone stimulation test: a possible aid in the evaluation of patients with adrenal insufficiency. , 1984, The Journal of clinical endocrinology and metabolism.

[25]  R. Post,et al.  Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. , 1984, The American journal of psychiatry.

[26]  H. Meltzer,et al.  Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. I. Enhanced response in depression and mania. , 1984, Archives of general psychiatry.

[27]  W. Vale,et al.  Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood , 1983, Brain Research.

[28]  L. Swanson,et al.  The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat , 1983, Brain Research.

[29]  J. Fozard.  The Peripheral actions of 5-hydroxytryptamine , 1989 .

[30]  H. Meltzer,et al.  Psychopharmacology : the third generation of progress , 1987 .

[31]  E. D. de Kloet,et al.  Selective control by corticosterone of serotonin1 receptor capacity in raphe-hippocampal system. , 1986, Neuroendocrinology.

[32]  W. Ganong,et al.  Serotonergic stimulation of prolactin and corticosterone secretion is mediated by different pathways from the mediobasal hypothalamus. , 1985, Neuroendocrinology.